Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
5.91
-0.20 (-3.35%)
Mar 31, 2025, 3:47 PM EDT - Market open
Journey Medical Employees
Journey Medical had 41 employees as of December 31, 2023. The number of employees increased by 21 or 105.00% compared to the previous year.
Employees
41
Change (1Y)
21
Growth (1Y)
105.00%
Revenue / Employee
$1,369,122
Profits / Employee
-$357,854
Market Cap
136.43M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 41 | 21 | 105.00% |
Dec 31, 2022 | 20 | -70 | -77.78% |
Dec 31, 2021 | 90 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DERM News
- 4 days ago - Journey Medical Corporation (DERM) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 7 days ago - Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea - GlobeNewsWire
- 11 days ago - Journey Medical Corporation to Announce Year End 2024 Financial Results on March 26, 2025 - GlobeNewsWire
- 19 days ago - Journey Medical Corporation to Participate in the 37th Annual ROTH Conference - GlobeNewsWire
- 25 days ago - Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea - GlobeNewsWire
- 26 days ago - Journey Medical Corporation to Exhibit at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida - GlobeNewsWire
- 7 weeks ago - Stock Picks From Seeking Alpha's January 2025 New Analysts - Seeking Alpha